SCHEMBL8993449

SCHEMBL8993449

CS(=O)(=O)c1cnc(CO)c(C2=CCCC2)c1

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 4/20 0.45
PSMB5 P28074 2/20 0.36
SCN9A Q15858 1/20 0.34
CSF1R P07333 3/20 0.33
PDGFRB P09619 1/20 0.33
PDGFRA P16234 1/20 0.33
GRM2 Q14416 1/20 0.32
S100A9 P06702 1/20 0.30
PTGDR2 Q9Y5Y4 1/20 0.30
NPC1 O15118 1/20 0.30
RAB9A P51151 1/20 0.30
FYN P06241 1/20 0.30
CCNE1 P24864 1/20 0.30
CDK2 P24941 1/20 0.30
MAP4K4 O95819 1/20 0.30
MINK1 Q8N4C8 1/20 0.30
TNIK Q9UKE5 1/20 0.30
PTGS1 P23219 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8993451 0.80 PTGS2 (0.39) PTGS2PDGFRBPDGFRAS100A9PTGS1
SCHEMBL8993514 0.74 PTGS2 (0.52) PTGS2GRM2PTGDR2
SCHEMBL8993563 0.68 PTGS2 (0.35) PTGS2
SCHEMBL6239385 0.67 PTGS2 (0.60) PTGS2PTGS1
SCHEMBL6239381 0.67 PTGS2 (0.60) PTGS2PTGS1
SCHEMBL8993493 0.66 ALDH1A1 (0.46) PTGS2GRM2CCNE1CDK2
SCHEMBL17202468 0.66 PTGS2 (0.46) PTGS2RAB9A
SCHEMBL4432809 0.66 LMNA (0.50) PTGS2GRM2RAB9A
SCHEMBL8993599 0.66 PTGS2 (0.49) PTGS2PTGS1
SCHEMBL8993654 0.64 F2RL1 (0.36) PSMB5GRM2CCNE1CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0724566-A1 1,2-DIARYLCYCLOPENTENYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-08-07 EP disclosed
WO-1995011883-A1 1,2-DIARYLCYCLOPENTENYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1995-05-04 WO disclosed